KBC Group NV »

Keros Therapeutics shares owned by KBC Group NV

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by KBC Group NV from 13F filings

Historical chart of KBC Group NV investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by KBC Group NV consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by KBC Group NV

Quarter filed Position value Share count Share price at filing
2024-09-30 $73k 1.3k 57.80
2024-06-30 $38k 831 45.73
2024-03-31 $51k 766 66.58